- Home
- ACRV vs CIIT Comparison
ACRV vs CIIT Comparison
Compare ACRV & CIIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- CIIT
- Stock Information
- Founded
- ACRV 2018
- CIIT N/A
- Country
- ACRV United States
- CIIT Hong Kong
- Employees
- ACRV N/A
- CIIT N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- CIIT
- Sector
- ACRV Health Care
- CIIT
- Exchange
- ACRV Nasdaq
- CIIT NYSE
- Market Cap
- ACRV 40.4M
- CIIT 36.0M
- IPO Year
- ACRV 2022
- CIIT N/A
- Fundamental
- Price
- ACRV $1.34
- CIIT $1.23
- Analyst Decision
- ACRV Buy
- CIIT
- Analyst Count
- ACRV 7
- CIIT 0
- Target Price
- ACRV $17.60
- CIIT N/A
- AVG Volume (30 Days)
- ACRV 379.9K
- CIIT 319.8K
- Earning Date
- ACRV 08-12-2025
- CIIT 06-09-2025
- Dividend Yield
- ACRV N/A
- CIIT N/A
- EPS Growth
- ACRV N/A
- CIIT N/A
- EPS
- ACRV N/A
- CIIT N/A
- Revenue
- ACRV N/A
- CIIT $9,464,501.00
- Revenue This Year
- ACRV N/A
- CIIT N/A
- Revenue Next Year
- ACRV N/A
- CIIT N/A
- P/E Ratio
- ACRV N/A
- CIIT N/A
- Revenue Growth
- ACRV N/A
- CIIT 51.52
- 52 Week Low
- ACRV $1.05
- CIIT $0.56
- 52 Week High
- ACRV $10.16
- CIIT $5.38
- Technical
- Relative Strength Index (RSI)
- ACRV 55.88
- CIIT N/A
- Support Level
- ACRV $1.15
- CIIT N/A
- Resistance Level
- ACRV $1.38
- CIIT N/A
- Average True Range (ATR)
- ACRV 0.09
- CIIT 0.00
- MACD
- ACRV 0.02
- CIIT 0.00
- Stochastic Oscillator
- ACRV 83.33
- CIIT 0.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About CIIT TIANCI INTERNATIONAL INC
Tianci International Inc along with its subsidiaries is engaged in sale of components of electronic devices, development of software and websites, technical consulting, and providing maintenance support on customized software. The company's business is predominantly carried out in Hong Kong with a substantial portion of its overall revenue being generated from its Electronic Device Hardware Components Sales segment.